Policy changes expanding access to patient health data and better fostering collaboration through transparency will be crucial to expediting patient access to new therapies, witnesses told members of the House Subcommittee on Health Tuesday, where lawmakers and experts alike testified to their frustrations over the yawning gap between the power data-sharing has enabled in the private sector and the barriers created by regulation and interoperability issues in American health care.